Chairman of the Board of Directors
Clive Beddoe, 74, is the Chairman of our Board of Directors and head of the Compensation Committee since April 2015. Mr. Beddoe is the CEO and Chairman of Hanover Holding and Investment Company, which he founded in 1977. Mr. Beddoe was the Founder and CEO of WestJet Airlines Ltd. from 1995 until 2007, and the Chairman of the Board of Directors of WestJet from 1995-2019. Mr. Beddoe served on the board of Alberta Investment Management Corporation (AIMco) from 2008-2014. Mr. Beddoe has been the recipient of honorary degrees from the University of Calgary and Wilfred Laurier University and was appointed the 2010-2011 Jarislowsky Resident Fellow in Business Management at the Haskayne School of Business at the University of Calgary. Mr. Beddoe was inducted into the Canadian Business Hall of Fame in 2012 and the Calgary Business Hall of Fame in 2013.
ROBERT L. CHIOINI
Director and Chief Executive Officer
Robert L. Chioini, 56, is the Chief Executive Officer of SQI Diagnostics, Inc. and has served in that position since August 2020. Prior to joining SQI, Mr. Chioini was the Founder, Chairman and Chief Executive Officer of Rockwell Medical, Inc. (NASDAQ: RMTI) from January 1995 to May 2018, where he built the business from inception into a vertically integrated publicly traded $950 million pharmaceutical drug and medical device company servicing the U.S. and global dialysis healthcare market. Mr. Chioini was a recipient of 40 Under 40 Crain’s Detroit Business in 2001, the winner of Ernst & Young Entrepreneur of Year Michigan Great Lakes Region in 2005 and from 2000-2018 served as a Board Member of Medical Main Street, an alliance of world-class hospitals, universities, medical device and biopharmaceutical companies creating a global center of innovation in health care, research and development, education and commercialization in the life sciences industry in Oakland County, Michigan. From 1987 to 1995, Mr. Chioini was a sales executive at medical manufacturing companies Tri-State Hospital Supply Corp. and Dial Medical, Inc. (acquired by Gambro Healthcare, Inc.), operating in the hospital supply and dialysis markets respectively. Mr. Chioini is a graduate of Michigan State University and earned his Bachelor of Arts degree in Advertising from the College of Communication Arts and Sciences in 1987.
Director and Chief Scientific Officer
Eric Brouwer, PhD, 53, is the Chief Scientific Officer of SQI Diagnostics, Inc. and has served in that position since October 2017. From April 2015 to May 2017, Mr. Brouwer was the Chief Scientific Officer of Trinity Biotech plc and then CEO of its subsidiary, Fiomi. From 2003 to 2015, Mr. Brouwer held various positions in Research and Development at Abbott Point of Care, including Senior Manager Research and Director of Assay Research and Development. While at Abbott, Mr. Brouwer developed and help launch a number of point of care diagnostics products, was the recipient of two divisional President’s Awards (2006, 2008) and the prestigious Chairman’s Award in 2007 and served as a member of the Abbott Scientific Governing Board. Mr. Brouwer also was a member of the Ottawa Life Sciences Council 2013 to 2014. From 2000 to 2003, Mr. Brouwer was a Senior Scientist at the point-of-care diagnostic innovator and industry leader i-STAT, prior to the acquisition of i-STAT by Abbott. Mr. Brouwer holds three U.S. patents and has authored over 30 peer-reviewed journal articles. Mr. Brouwer holds multiple degrees in chemistry from Queen’s University (BSc(Hons)), University of British Columbia (MSc) and Carleton University (PhD) and a post-doctoral fellowship at the University of Durham (UK).
GERALD R. CONNOR
Gerald R. Connor, 75, is a member of our Board of Directors. Mr. Connor is currently Chairman of Cumberland Private Wealth Management Inc., which he founded in in 1997. From 1977 to 1997, Mr. Connor was co-Founder and President of Connor, Clark & Company. During this period, Mr. Connor was also co-Founder and Chairman of Connor, Clark & Lunn and 20/20 Investment Management. Mr. Connor is currently a trustee of Allied Properties Real Estate Investment Trust which he co-founded in 1998 and serves as Chair of the audit committee. Mr. Connor graduated with a BA from DePauw University.
WILMOT L. MATTHEWS
Wilmot L. Matthews, 84, is a member of our Board of Directors since April 2015. Mr. Matthews is the President of private investment company Marjad Inc., which he founded in 1995. Mr. Matthews is also a member of the Investment Advisory Committee of Imperial Capital. Mr. Matthews served as Vice Chairman of Nesbitt Burns, formerly known as Nesbitt Thomson, a wholly-owned subsidiary of The Bank of Montreal, from 1994-1996. From 1963-1994, Mr. Matthews served as a fund analyst, fund manager and co-head of corporate and government services for Fry & Company Limited, prior to its merger with Nesbitt Thomson. Mr. Matthews received his Bachelor of Arts in Math, Physics and Chemistry from the University of Toronto in 1958, and both his Master of Business Administration degree from the London School of Economics in Business Administration and his Master of Science in Economics from the London School of Economics in London, England in 1964.
Eric Zwisler, 60, is a member of our Board of Directors since June 2018. Mr. Zwisler is Chairman of the Board of the La Jolla Institute for Immunology, one of the world’s top-five biomedical research institutes focused on understanding the immune response to infectious agents and cancers, since 2019. From 2013 – 2018 Mr. Zwisler was the Chairman of Cardinal Health China, a subsidiary of Cardinal Health (NYSE: CAH). He is also Chairman of the Board of ITG, a private sustainable insect protein business in London and serves as board member to several other organizations. From 2002-2014, Mr. Zwisler served as a board member of the International Federation of Pharmaceutical Wholesalers, serving as Chairman of the Board 2012 to 2014. Mr. Zwisler is a graduate of Carroll College (BA Economics 1980) and the University of Michigan (MBA 1982).
Andrew Morris, 55, is a member of our Board of Directors since October 2013. Mr. Morris is currently Managing Partner, CFO and COO of ATWILL Medical Solutions LP. From October 2013 to March 2020, Mr. Morris was the CEO of SQI Diagnostics. From 2004-2013, Mr. Morris was the Chief Financial Officer of SQI Diagnostics. From 2001 to 2004, Mr. Morris was VP Mergers and Acquisitions of the Corporate Finance Life Sciences group at Ernst & Young. From 1999 to 2001, he was Director Finance at Norigen Communications. Mr. Morris was a staff scientist with the rank of Captain at the Defence and Civil Institute of Environmental Medicine, Canada from 1988 to 1999. Mr. Morris earned his Honours Bachelor of Science degree from the University of Western Ontario in 1988, a Master’s of Science degree from the Faculty of Medicine at the University of Toronto in 1996, and a Master’s of Business Administration degree from the Rotman School of Management at the University of Toronto in 1998.
Claude Ricks, 64, is a member of our Board of Directors and head of the Audit Committee since 2015. Mr. Ricks is a Managing Partner of Level5 Strategy since January 2017. From 2014-2016, Mr. Ricks was COO of gshift. Mr. Ricks was President and CEO of SQI Diagnostics from 2004-2013 and Board Chairman from June 2013-2014. From 1998-2002, Mr. Ricks was VP of Revenue for Solect Technology. Mr. Ricks is a graduate of Western University and earned his Bachelor of Science degree in Chemistry in 1979.